Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T18515 | Palbociclib-propargyl
化合物 T18515
|
2366269-23-8 | 98% |
|
Palbociclib-propargyl, a PROTAC ligand targeting the protein CDK6, connects to the CRBN ligand through a PEG linker to form PROTAC CP-10. CP-10 exhibits a potent... | ||||
T18641 | SirReal1-O-propargyl
化合物 T18641
|
1862237-99-7 | 98% |
|
SirReal1-O-propargyl is a selective and highly potent Sirtuin 2 (Sirt2) inhibitor, with an IC50 of 2.4 μM. SirReal1-O-propargyl, the SirReal1-based moiety, binds... | ||||
T18599 | PROTAC BRD4-binding moiety 1
化合物 T18599
|
2101200-10-4 | 98% |
|
PROTAC BRD4-binding moiety 1 is a BRD4 ligand that binds to the cereblon ligand through a linker, enabling the formation of a PROTAC complex. This complex effici... | ||||
T19172 | A-1210477-piperazinyl
化合物 T19172
|
2351218-72-7 | 98% |
|
A-1210477-piperazinyl is a compound that specifically targets and binds to the protein myeloid cell leukemia 1 (MCL1). This compound is utilized in PROTAC techno... | ||||
T10734 | CDK ligand for PROTAC
化合物 T10734
|
T10734 | 98% |
|
CDK ligand for PROTAC is a CDK inhibitor with antitumor activity. It has been used to design PROTAC CDK4/6 degraders. | ||||
T14288 | Androstanolone acetate
化合物 T14288
|
1164-91-6 | 98% |
|
Androstanolone acetate is a compound that functions as an androgen ligand, specifically targeting the androgen receptor (AR). It binds to the cIAP1 ligand Bestat... | ||||
T13549 | AP1867-3-(aminoethoxy)
化合物 T13549
|
2127390-15-0 | 98% |
|
AP1867-3-(aminoethoxy) is a synthetic ligand for FKBP and can be used in the synthesis of PROTAC FKBP12 F36V degrader. | ||||
T13915L | PROTAC BRD9-binding moiety 1 hydrochloride
化合物 T13915L
|
T13915L | 98% |
|
PROTAC BRD9-binding moiety 1 hydrochloride binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC. | ||||
T10716 | CCR7 Ligand 1
化合物 T10716
|
681514-83-0 | 98% |
|
CCR7 Ligand 1 (CCR7-Cmp2105) is an allosteric Ligand and antagonist for human CC chemokine receptor 7 (CCR7) with a Kd of 3 nM. CCR7 Ligand 1, thiadiazole-dioxid... | ||||
T17733 | ATRA-hydroxyimino
化合物 T17733
|
135325-47-2 | 98% |
|
ATRA-hydroxyimino, also known as CRABP-II ligand 1, is a chemical compound derived from Retinoic acid (ATRA). This compound binds to the cIAP1 ligand, specifical... | ||||
T18593 | GNF5-amido-Me
化合物 T18593
|
778277-37-5 | 98% |
|
GNF5-amido-Me, the moiety based on GNF5 (ABL inhibitor),binds through a linker to the IAP ligand forming SNIPER[1]. | ||||
T13765 | MAK683-CH2CH2COOH
化合物 T13765
|
2639882-68-9 | 98% |
|
MAK683-CH2CH2COOH 与 EED (胚胎外胚层发育蛋白) 结合。基于MAK683-CH2CH2COOH 和 E3 泛素连接酶的 VHL 配体,设计了靶向EED 的PROTACs, PROTAC EED degrader-1 和 PROTAC EED degrader-2 。 | ||||
T17931 | EED226-COOH
化合物 T17931
|
T17931 | 98% |
|
EED226-COOH, derived from EED226, serves as a ligand targeting the EED protein for PROTAC applications. It attaches to a VHL ligand through a linker, culminating... | ||||
T18594 | HG-7-85-01-Decyclopropane
化合物 T18594
|
T18594 | 98% |
|
Decyclopropane, also known as HG-7-85-01, is a chemical compound with ABL inhibitor properties. It binds to the IAP ligand through a linker, resulting in the for... | ||||
T13696 | FN-1501-propionic acid
化合物 T13696
|
2408642-48-6 | 98% |
|
FN-1501-propionic acid, a CDK2/9 ligand, in conjunction with a CRBN ligand, has been utilized in the design of a PROTAC CDK2/9 degrader. | ||||
T1835 | Ibrutinib
伊布替尼
|
936563-96-1 | 99.79% |
|
Ibrutinib (PCI-32765) 是一种不可逆的、选择性的 Btk 抑制剂,IC50=0.5 nM,它是一种 Btk 配体,用于合成一系列 PROTAC 分子,如 P13I。P13I 作用于人 Burkitt’s 淋巴瘤 RAMOS 细胞,浓度为 10 和 100 nM 时,分别降解 73% 和 89% Btk... | ||||
T19301 | DUPA
化合物DUPA
|
302941-52-2 | 99.56% |
|
DUPA (N,N''-Carbonylbis[L-glutamic acid]) 是谷氨酸脲,在药物偶联中作为靶向部分,可选择靶向性地将细胞毒性药物递送到前列腺癌细胞。 | ||||
T12551 | PROTAC BRD4 ligand-1
化合物PROTAC BRD4 ligand-1
|
2313230-51-0 | 99.48% |
|
PROTAC BRD4 ligand-1 是 PROTAC GNE-987 靶向 BRD4 蛋白的配体,也是一种 BET 的抑制剂。 | ||||
T2066 | Quizartinib
奎扎替尼
|
950769-58-1 | 99.42% |
|
Quizartinib (AC220) 是一种具有口服活性的高选择性Ⅱ 型 FLT3酪氨酸激酶抑制剂,可诱导细胞凋亡。它抑制 Wt FLT3 和 突变型 FLT3-ITD 自磷酸化,IC50分别为 4.1 nM 和 1.1 nM。它可通过优化的 linker 与 VHL 配体连接,从而形成 PROTAC Flt3 降解剂... | ||||
T12186 | Navitoclax-piperazine
化合物Navitoclax-piperazine
|
2143096-93-7 | 99.11% |
|
Navitoclax-piperazine (ABT-263-piperazine) 是一种特大型 B 细胞淋巴瘤(BCL-XL)抑制剂。它和 E3 泛素连接酶的 VHL 配体可用来合成 PROTAC DT2216。 |